If such kind of regulation of GSTO2 expression also exists in TCC cells, GSTO1 or GSTO2 polymorphisms would presumably result in deficient DHAR activity, and lower ascorbic acid level (AA) in tumor. This evidence concerns the gene GSTO2 and neoplasm.